Lars Rydén
Impact in
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
Papers in
-
- Diabetes Treatment and Management 33
- Diabetes, Cardiovascular Risks, and Lipoproteins 18
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 18
- Diabetes Management and Research 17
-
- Cardiovascular Function and Risk Factors 11
- Co-authors
- Hans Wedel (11 shared papers)Klas Malmberg (9 shared papers)Suad Efendić (6 shared papers)Anna Norhammar (32 shared papers)Anders Waldenström (3 shared papers)Johan Herlitz (2 shared papers)Peter Nicol (1 shared paper)Lennart Welin (1 shared paper)
- Journals
- Diabetes and Vascular Disease Research (17 papers)Diabetes Care (16 papers)European Heart Journal (15 papers)European Journal of Preventive Cardiology (13 papers)Cardiovascular Diabetology (7 papers)
- Partner nations
- SwedenUnited KingdomGermany
In The Last Decade
Lars Rydén
156 papers receiving 6.4k citations
Lars Rydén's Hit Papers
Peers
Comparison fields: 5 of 132
- Endocrinology, Diabetes and Metabolism 3.2k
- Cardiology and Cardiovascular Medicine 2.1k
- Periodontics 80
- Internal Medicine 55
- Surgery 684
Countries citing papers authored by Lars Rydén
This map shows the geographic impact of Lars Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Rydén more than expected).
Fields of papers citing papers by Lars Rydén
This network shows the impact of papers produced by Lars Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Rydén. The network helps show where Lars Rydén may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year Hit paper breakdown → | 1995 | 1151 |
| 2 | Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Hit paper breakdown → | 2005 | 757 |
| 3 | 2001 | 381 | |
| 4 | 2004 | 244 | |
| 5 | 2014 | 196 | |
| 6 | 2010 | 136 | |
| 7 | 2007 | 131 | |
| 8 | 2006 | 131 | |
| 9 | 2007 | 126 | |
| 10 | Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial Hit paper breakdown → | 2024 | 120 |
| 11 | 2011 | 103 | |
| 12 | 2004 | 102 | |
| 13 | 2003 | 93 | |
| 14 | 2007 | 84 | |
| 15 | 2011 | 81 | |
| 16 | 2004 | 77 | |
| 17 | 2015 | 74 | |
| 18 | 2007 | 72 | |
| 19 | 2017 | 69 | |
| 20 | 2014 | 66 |
About Lars Rydén
Lars Rydén is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery and Epidemiology, having authored 161 papers that have together received 6.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (18 papers), Diabetes Management and Research (17 papers), Metabolism, Diabetes, and Cancer (16 papers), Cardiovascular Function and Risk Factors (11 papers), Lipoproteins and Cardiovascular Health (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.2k citations), Cardiology and Cardiovascular Medicine (2.1k citations), Periodontics (80 citations), Internal Medicine (55 citations) and Surgery (684 citations). Lars Rydén has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Hans Wedel, Klas Malmberg, Suad Efendić, Anna Norhammar, Anders Waldenström, Johan Herlitz, Peter Nicol, Lennart Welin, Linda Mellbin and John Öhrvik. Their work appears in journals such as Diabetes and Vascular Disease Research, Diabetes Care, European Heart Journal, European Journal of Preventive Cardiology and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.